Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea

• Prif Awduron: Jieun Kang (Awdur), Kwan Ho Lee (Awdur), Jae Ha Lee (Awdur), Yi Yeong Jeong (Awdur), Sun Mi Choi (Awdur), Ho Cheol Kim (Awdur), Joo Hun Park (Awdur), Hyun-Kyung Lee (Awdur), Suk Joong Yong (Awdur), Hye Sook Choi (Awdur), Hak Ryul Kim (Awdur), Yangjin Jegal (Awdur), Won-il Choi (Awdur), Eun Joo Lee (Awdur), Jin Woo Song (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

BackgroundPirfenidone is an antifibrotic medication approved for idiopathic pulmonary fibrosis (IPF). Fybro®, a generic version of pirfenidone developed in South Korea, gained approval and is available in 200 mg and in higher-dose formulations of 400 and 600 mg. This real-world prospective cohort st...